eNews
Home page > Comments


Comments

FDA seeks data on delivery method for Amylin drug

06.06.2012. | (Reuters) - Amylin Pharmaceuticals Inc said U.S. health regulators have requested data on a new delivery system for its recently approved long-acting diabetes drug Bydureon....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: